Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Tamiflu oseltamivir: Additional Phase III data

Additional data from a Phase III trial in children 1 year and older

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE